RECURRENT NON SMALL CELL LUNG CANCER
Clinical trials for RECURRENT NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RECURRENT NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation combo aims to shrink inoperable lung tumors
Disease control OngoingThis study tested a new way of giving radiation therapy (called hypofractionated radiotherapy with a stereotactic boost) along with standard chemotherapy for people with stage II or III non-small cell lung cancer that cannot be removed by surgery. The goal was to find the highest…
Matched conditions: RECURRENT NON SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:57 UTC
-
New combo therapy shows promise in advanced lung cancer trial
Disease control OngoingThis study tests whether adding a new drug (relatlimab) to standard immunotherapy (nivolumab) and chemotherapy works better than nivolumab plus chemotherapy alone for people with advanced or recurrent non-small cell lung cancer. About 468 participants will receive one of the two …
Matched conditions: RECURRENT NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 06:46 UTC